​Beleave Inc. (BE: CNX) Obtains ACMPR License to Cultivate Medical Cannabis

Spotlight Companies |

Beleave Inc.'s (BE: CNX) wholly owned subsidiary, First Access Medical Inc. (FAM), has been granted a licence to cultivate medical cannabis pursuant to the access to cannabis for medical purposes regulations (ACMPR).

"We are ecstatic to have achieved our goal of becoming a licensed producer," commented Beleave chief executive officer Roger Ferreira. "We have remained diligent and focused throughout the process and understand that this is just the beginning of a much bigger plan and vision for Beleave. We remain committed to building a strong foundation of research expertise that we hope will translate into the cultivation of exceptional products for qualified Canadians. Finally, we would like to thank all of our stakeholders for their patience and support over the past three years. We very much look forward to growing with you."

About Beleave Inc.



Beleave Inc. is a biotechnology company and Beleave's wholly owned subsidiary, FAM, is a licensed producer pursuant to the ACMPR. Beleave's purpose-built facility is located in Hamilton, Ont.

In the interest of full disclosure, we call the reader's attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
BE:CNX Beleave Inc. 1.97 -0.08 -3.90 155,626

Comments

Trending Articles

  • No items found.

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…

Trustify

Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…